Postoperative screening for distress symptom cluster in patients with pituitary adenomas: a propensity-score matched outcome analysis - Takeaways - MDSpire

Postoperative screening for distress symptom cluster in patients with pituitary adenomas: a propensity-score matched outcome analysis

  • By

  • Dan Wang

  • Qian Zhang

  • Ru Ling

  • Zhizhi Li

  • Xiling Xia

  • Haiyan Qiu

  • May 8, 2026

  • 0 min

Share

  • 1

    The study evaluated postoperative distress symptom screening in 334 patients undergoing surgery for pituitary adenoma.

  • 2

    Patients in the screening group reported significantly lower PROMIS scores for pain interference, fatigue, and sleep disruption compared to controls.

  • 3

    Screening was associated with reduced inflammatory cytokines and lower rates of hospital readmission and failure to return to work.

  • 4

    The assessment for distress symptom clusters improved patients' quality of life as measured by EQ-5D scores within six months post-surgery.

  • 5

    Minor adverse events were reported in 7.8% of patients who participated in the screening for distress symptoms.

Original Source(s)

Postoperative screening for distress symptom cluster in patients with pituitary adenomas: a propensity-score matched outcome analysis

  • by Dan Wang, Qian Zhang, Ru Ling, Zhizhi Li, Xiling Xia, Haiyan Qiu

  • May 8, 2026

Related Content

Side Effects: Medicine's Blind Spot

Medicine is having a week: new insights on nutrition training, a rethink of “spring fatigue,” evidence that avocados may support artery health, and an AI that can spot rare hormone tumors from a hand photo

Combo Therapy for Psoriasis With Obesity

A phase 3b trial tests ixekizumab plus tirzepatide in adults with moderate-to-severe plaque psoriasis and obesity or overweight.

FDA Okays Weekly Option in Achondroplasia

Navepegritide is described as the first therapy to deliver continuous C-type natriuretic peptide exposure over a weekly dosing interval in eligible pediatric patients.